CD38 and neoplasm: As shown in Figures 3B, C, the results of bioluminescence imaging in vivo showed that compared with the control group or Pan-T group, the tumor of the CD38 CAR-T cell groups was cleared completely after the second injection of CD38 CAR-T cells.